(0.29%) 5 562.25 points
(0.04%) 39 567 points
(0.43%) 20 126 points
(0.64%) $82.26
(0.89%) $2.71
(0.04%) $2 337.50
(0.66%) $29.45
(1.92%) $1 010.70
(0.12%) $0.935
(0.39%) $10.67
(0.03%) $0.791
(1.77%) $86.50
0.93% HKD 5.40
Live Chart Being Loaded With Signals
Shandong Xinhua Pharmaceutical Company Limited, through its subsidiaries, develops, manufactures, and sells bulk pharmaceuticals, preparations, and chemical products...
Stats | |
---|---|
Dzisiejszy wolumen | 216 910 |
Średni wolumen | 1.26M |
Kapitalizacja rynkowa | 8.92B |
EPS | HKD0.210 ( Q1 | 2024-03-31 ) |
Następna data zysków | ( HKD0 ) 2024-08-21 |
Last Dividend | HKD0.219 ( 2023-07-07 ) |
Next Dividend | HKD0 ( N/A ) |
P/E |
7.11 (Sector) 14.27 (Industry) 0 |
ATR14 | HKD0.0150 (0.28%) |
Wolumen Korelacja
Shandong Xinhua Korelacja
10 Najbardziej pozytywne korelacje |
---|
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Shandong Xinhua Korelacja - Waluta/Towar
Shandong Xinhua Finanse
Annual | 2023 |
Przychody: | HKD8.10B |
Zysk brutto: | HKD2.39B (29.52 %) |
EPS: | HKD0.740 |
FY | 2023 |
Przychody: | HKD8.10B |
Zysk brutto: | HKD2.39B (29.52 %) |
EPS: | HKD0.740 |
FY | 2022 |
Przychody: | HKD7.50B |
Zysk brutto: | HKD2.04B (27.15 %) |
EPS: | HKD0.620 |
FY | 2021 |
Przychody: | HKD6.56B |
Zysk brutto: | HKD1.77B (27.04 %) |
EPS: | HKD0.560 |
Financial Reports:
No articles found.
Shandong Xinhua Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
HKD0.176 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0.219 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | HKD0.0308 | 2000-05-10 |
Last Dividend | HKD0.219 | 2023-07-07 |
Next Dividend | HKD0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 23 | -- |
Total Paid Out | HKD1.419 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 3.66 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 6.81 | |
Div. Directional Score | 9.77 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Ex Date | Amount | Declaration Date | Record Date | Payment Date |
---|---|---|---|---|
07 Jul 2023 | HKD0.219 | 30 Nov -0001 | 30 Nov -0001 | 30 Nov -0001 |
15 Jul 2022 | HKD0.176 | 30 Nov -0001 | 30 Nov -0001 | 30 Nov -0001 |
14 Jul 2021 | HKD0.180 | 30 Nov -0001 | 30 Nov -0001 | 30 Nov -0001 |
17 Jul 2020 | HKD0.131 | 30 Nov -0001 | 30 Nov -0001 | 30 Nov -0001 |
05 Jul 2019 | HKD0.114 | 30 Nov -0001 | 30 Nov -0001 | 30 Nov -0001 |
06 Jul 2018 | HKD0.0601 | 30 Nov -0001 | 30 Nov -0001 | 30 Nov -0001 |
27 Dec 2017 | HKD0.0300 | 30 Nov -0001 | 30 Nov -0001 | 30 Nov -0001 |
04 Jul 2016 | HKD0.0181 | 30 Nov -0001 | 30 Nov -0001 | 30 Nov -0001 |
30 Jun 2015 | HKD0.0192 | 30 Nov -0001 | 30 Nov -0001 | 30 Nov -0001 |
06 Jun 2014 | HKD0.0192 | 30 Nov -0001 | 30 Nov -0001 | 30 Nov -0001 |
30 May 2013 | HKD0.00962 | 30 Nov -0001 | 30 Nov -0001 | 30 Nov -0001 |
29 Jun 2012 | HKD0.0283 | 30 Nov -0001 | 30 Nov -0001 | 30 Nov -0001 |
26 May 2011 | HKD0.0454 | 30 Nov -0001 | 30 Nov -0001 | 30 Nov -0001 |
24 May 2010 | HKD0.0385 | 30 Nov -0001 | 30 Nov -0001 | 30 Nov -0001 |
07 May 2009 | HKD0.0231 | 30 Nov -0001 | 30 Nov -0001 | 30 Nov -0001 |
23 May 2008 | HKD0.0231 | 30 Nov -0001 | 30 Nov -0001 | 30 Nov -0001 |
14 May 2007 | HKD0.0154 | 30 Nov -0001 | 30 Nov -0001 | 30 Nov -0001 |
08 May 2006 | HKD0.0385 | 30 Nov -0001 | 30 Nov -0001 | 30 Nov -0001 |
06 May 2004 | HKD0.0308 | 30 Nov -0001 | 30 Nov -0001 | 30 Nov -0001 |
07 May 2003 | HKD0.0462 | 30 Nov -0001 | 30 Nov -0001 | 30 Nov -0001 |
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
1772.HK | Ex Dividend Junior | 2023-07-03 | Annually | 0 | 0.00% | |
0239.HK | Ex Dividend Knight | 2023-09-29 | Semi-Annually | 0 | 0.00% | |
8053.HK | No Dividend Player | 2023-09-28 | Annually | 0 | 0.00% | |
1271.HK | Ex Dividend Junior | 2023-08-10 | Semi-Annually | 0 | 0.00% | |
2688.HK | Ex Dividend Knight | 2023-11-02 | Annually | 0 | 0.00% | |
0842.HK | Ex Dividend Junior | 2023-09-04 | Sporadic | 0 | 0.00% | |
1981.HK | Ex Dividend Junior | 2023-10-20 | Annually | 0 | 0.00% | |
0405.HK | Ex Dividend Knight | 2023-09-12 | Semi-Annually | 0 | 0.00% | |
1513.HK | Ex Dividend Knight | 2023-07-04 | Annually | 0 | 0.00% | |
0064.HK | Ex Dividend Knight | 2023-08-29 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0613 | 1.500 | 8.77 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0575 | 1.200 | 8.08 | 9.70 | [0 - 0.3] |
returnOnEquityTTM | 0.107 | 1.500 | 9.92 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0.356 | -1.000 | 6.44 | -6.44 | [0 - 1] |
currentRatioTTM | 1.425 | 0.800 | 7.87 | 6.30 | [1 - 3] |
quickRatioTTM | 0.916 | 0.800 | 9.32 | 7.46 | [0.8 - 2.5] |
cashRatioTTM | 0.378 | 1.500 | 9.01 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.155 | -1.500 | 7.41 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 13.47 | 1.000 | 6.12 | 6.12 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.721 | 2.00 | 9.76 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.245 | 2.00 | 9.88 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.276 | -1.500 | 8.90 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.283 | 1.000 | 8.62 | 8.62 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0654 | 1.000 | -0.691 | -0.691 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.370 | 1.000 | 9.05 | 9.05 | [0.2 - 2] |
assetTurnoverTTM | 0.937 | 0.800 | 7.09 | 5.67 | [0.5 - 2] |
Total Score | 12.73 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 6.90 | 1.000 | 9.40 | 0 | [1 - 100] |
returnOnEquityTTM | 0.107 | 2.50 | 9.95 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.245 | 2.00 | 9.92 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 4.41 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.721 | 2.00 | 9.76 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.356 | 1.500 | 6.44 | -6.44 | [0 - 1] |
pegRatioTTM | 0.766 | 1.500 | 8.23 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0614 | 1.000 | -0.966 | 0 | [0.1 - 0.5] |
Total Score | 6.81 |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Shandong Xinhua
Shandong Xinhua Pharmaceutical Company Limited, through its subsidiaries, develops, manufactures, and sells bulk pharmaceuticals, preparations, and chemical products. It operates through Chemical bulk drugs, Preparations, and Chemical intermediates and Others segments. The company offers active pharmaceutical ingredients, pharmaceutical preparations, and chemical products, such as antipyretic analgesics; drugs for cardiovascular and cerebrovascular diseases; anti-infectives; drugs for diseases related to the central nervous system; and other drugs under the Xinhua brand. It also provides prepared Chinese herbal medicine decoction, traditional Chinese medicines, chemical preparations, antibiotics, biochemical medicines, chemical bulk drugs, anesthetics, anti-psychotic drugs, pharmaceutical precursor chemicals, protein assimilation preparations, peptide hormones, medical toxic drugs, etc.; and chemical raw materials, such as dimethyl sulfate, isobutylbenzene, 1,8-diazabicyclo, undec-7-ene, and tetramethylguanidine. In addition, the company offers materials and intermediates, powders for injection and tablets; tablets, hard capsules, granules, and dry suspension; imports and exports goods and technologies; designs medical projects; and health products research and development activities. Further, it engages in the certification business; electrical equipment engineering; and installation and testing of chemical equipment and electrical equipment, as well as the sale of mechanical, hardware, and electrical equipment. Additionally, the company produces and sells high-end steroid system APIs and intermediates; and provides internet data, internet sells, and internet information services for pharmaceuticals and medical devices, etc. It operates in the People's Republic of China, the Americas, Europe, and internationally. Shandong Xinhua Pharmaceutical Company Limited was founded in 1943 and is based in Zibo, the People's Republic of China.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej